This Article Full Text Full Text (PDF) All Versions of this Article: 2/1/35    most recent CIRCINTERVENTIONS.108.805630v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Applegate, R. J. Articles by Little, W. C. Search for Related Content PubMed Articles by Applegate, R. J. Articles by Little, W. C. Related Collections Catheter-based coronary interventions: stents Related Article

Original Articles

Effect of Length and Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes

Robert J. Applegate, MD, FACC; Matthew T. Sacrinty, MPH; Michael A. Kutcher, MD, FACC; Renato M. Santos, MD, FACC; Sanjay K. Gandhi, MD, FACC and William C. Little, MD, FACC

From the Wake Forest University School of Medicine, Section of Cardiology, Winston-Salem, NC.

Correspondence to Robert J. Applegate, MD, Section of Cardiology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1045. E-mail bapplega{at}wfubmc.edu

Received July 8, 2008; accepted November 30, 2008.

Background— The risk of restenosis and other adverse cardiac events with bare-metal stents (BMS) is increased with smaller stent diameters and longer stent lengths. Drug-eluting stents (DES) may reduce this effect in select patients; however, whether this benefit occurs in high-risk lesions and patients in routine practice is not clear.

Methods and Results— Clinical outcomes (target-vessel revascularization [TVR], stent thrombosis, nonfatal myocardial infarction [MI], and cardiac death) at 2 years stratified by stented length and diameter were compared in 949 consecutive patients who received BMS and 1236 consecutive and comparable patients who received DES for single lesions. The longest tertile of BMS (>23 mm) was associated with increased hazard of TVR, ST, and nonfatal MI or death compared with shorter tertiles of BMS, which was abolished by DES. DES compared with BMS was independently associated with a lower hazard of TVR (HR, 0.34 [0.20 to 0.58]) and nonfatal MI or death (HR, 0.60 [0.39 to 0.92]) in the longest length tertile (>23 mm). No clear association of stented tertile diameter and clinical outcomes for either stent type was observed. However, DES compared with BMS was independently associated with a lower hazard of TVR for all diameter tertiles, and a lower hazard of nonfatal MI or death (0.66 [0.44 to 0.99]) in the largest diameter tertile (>3.4 mm).

Conclusions— Independent of adverse patient and lesion characteristics, DES demonstrated significantly lower hazard of TVR and nonfatal MI or death at 2 years compared with BMS within the longest stented lengths (>23 mm) and largest diameters (>3.4 mm).

Key Words: angioplasty • mortality • stents

---

 

CLINICAL PERSPECTIVE

Related Article

Effect of Length and Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes

Robert J. Applegate, Matthew T. Sacrinty, Michael A. Kutcher, Renato M. Santos, Sanjay K. Gandhi, and William C. Little
Circ Cardiovasc Interv 2009 2: 35-42. [Abstract] [Full Text] [PDF]